INS and type 2 diabetes mellitus: Additionally, the patient population in this study had advanced T2D, as indicated by the mean disease duration of 11.8 years from diagnosis and the complex pharmacological treatment at baseline, with 41.9% of patients taking more than two antihyperglycaemic medications and 47.5% taking insulin.